25 XP   0   0   10

Active Biotech AB
Buy, Hold or Sell?

Let's analyse Active Biotech AB together

PenkeI guess you are interested in Active Biotech AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Active Biotech AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Active Biotech AB

I send you an email if I find something interesting about Active Biotech AB.

Quick analysis of Active Biotech AB (30 sec.)










What can you expect buying and holding a share of Active Biotech AB? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.08
Expected worth in 1 year
kr0.07
How sure are you?
15.0%

+ What do you gain per year?

Total Gains per Share
kr-0.01
Return On Investment
-2.0%

For what price can you sell your share?

Current Price per Share
kr0.55
Expected price per share
kr0.516 - kr0.67
How sure are you?
50%

1. Valuation of Active Biotech AB (5 min.)




Live pricePrice per Share (EOD)

kr0.55

Intrinsic Value Per Share

kr-4.37 - kr-2.19

Total Value Per Share

kr-4.29 - kr-2.11

2. Growth of Active Biotech AB (5 min.)




Is Active Biotech AB growing?

Current yearPrevious yearGrowGrow %
How rich?$2.8m$3m-$1.4m-97.0%

How much money is Active Biotech AB making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$1.3m$320.6k30.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Active Biotech AB (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#795 / 1011

Most Revenue
#914 / 1011

Most Profit
#241 / 1011

Most Efficient
#350 / 1011

What can you expect buying and holding a share of Active Biotech AB? (5 min.)

Welcome investor! Active Biotech AB's management wants to use your money to grow the business. In return you get a share of Active Biotech AB.

What can you expect buying and holding a share of Active Biotech AB?

First you should know what it really means to hold a share of Active Biotech AB. And how you can make/lose money.

Speculation

The Price per Share of Active Biotech AB is kr0.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Active Biotech AB.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Active Biotech AB, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.08. Based on the TTM, the Book Value Change Per Share is kr0.00 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Active Biotech AB.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.00-0.6%0.00-0.5%0.00-0.7%0.00-0.5%-0.01-1.0%
Usd Book Value Change Per Share0.011.4%0.000.0%0.00-0.2%0.00-0.1%0.00-0.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.011.4%0.000.0%0.00-0.2%0.00-0.1%0.00-0.4%
Usd Price Per Share0.04-0.07-0.10-0.15-0.65-
Price to Earnings Ratio-3.30--5.68--6.60--16.71--29.75-
Price-to-Total Gains Ratio5.64--18.05--17.27--61.96--104.01-
Price to Book Ratio5.40-62.32-14.11-25.27-23.37-
Price-to-Total Gains Ratio5.64--18.05--17.27--61.96--104.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.050545
Number of shares19784
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (19784 shares)-4.91-14.40
Gains per Year (19784 shares)-19.66-57.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-20-300-58-68
20-39-500-115-126
30-59-700-173-184
40-79-900-230-242
50-98-1100-288-300
60-118-1300-346-358
70-138-1500-403-416
80-157-1700-461-474
90-177-1900-519-532
100-197-2100-576-590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%5.057.017.06.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%6.034.00.015.0%18.061.00.022.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.079.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%6.034.00.015.0%18.061.00.022.8%

Fundamentals of Active Biotech AB

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Biotech AB (publ) was incorporated in 1983 and is headquartered in Lund, Sweden.

Fundamental data was last updated by Penke on 2024-04-19 00:57:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Active Biotech AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Active Biotech AB earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Active Biotech AB to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Active Biotech AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-297.8%+297.8%
5Y-297.8%10Y-503.3%+205.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--196.1%+196.1%
TTM--211.9%+211.9%
YOY--277.7%+277.7%
5Y-297.8%-432.9%+135.1%
10Y-503.3%-599.3%+96.0%
1.1.2. Return on Assets

Shows how efficient Active Biotech AB is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Active Biotech AB to the Biotechnology industry mean.
  • -28.4% Return on Assets means that Active Biotech AB generated kr-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Active Biotech AB:

  • The MRQ is -28.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -44.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.4%TTM-44.1%+15.7%
TTM-44.1%YOY-33.4%-10.7%
TTM-44.1%5Y-24.6%-19.5%
5Y-24.6%10Y-15.5%-9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.4%-13.3%-15.1%
TTM-44.1%-12.7%-31.4%
YOY-33.4%-11.8%-21.6%
5Y-24.6%-14.0%-10.6%
10Y-15.5%-15.9%+0.4%
1.1.3. Return on Equity

Shows how efficient Active Biotech AB is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Active Biotech AB to the Biotechnology industry mean.
  • -40.7% Return on Equity means Active Biotech AB generated kr-0.41 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Active Biotech AB:

  • The MRQ is -40.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -249.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.7%TTM-249.7%+209.0%
TTM-249.7%YOY-52.8%-197.0%
TTM-249.7%5Y-72.1%-177.6%
5Y-72.1%10Y-44.5%-27.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.7%-16.9%-23.8%
TTM-249.7%-16.0%-233.7%
YOY-52.8%-15.1%-37.7%
5Y-72.1%-19.7%-52.4%
10Y-44.5%-20.5%-24.0%

1.2. Operating Efficiency of Active Biotech AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Active Biotech AB is operating .

  • Measures how much profit Active Biotech AB makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Active Biotech AB to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Active Biotech AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-283.8%+283.8%
5Y-283.8%10Y-471.2%+187.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--290.9%+290.9%
TTM--224.4%+224.4%
YOY--288.3%+288.3%
5Y-283.8%-479.5%+195.7%
10Y-471.2%-625.2%+154.0%
1.2.2. Operating Ratio

Measures how efficient Active Biotech AB is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Active Biotech AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y3.440-3.440
5Y3.44010Y5.370-1.930
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.110-3.110
TTM-3.266-3.266
YOY-3.783-3.783
5Y3.4405.657-2.217
10Y5.3707.783-2.413

1.3. Liquidity of Active Biotech AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Active Biotech AB is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.72 means the company has kr3.72 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Active Biotech AB:

  • The MRQ is 3.721. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.333. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.721TTM2.333+1.388
TTM2.333YOY3.651-1.318
TTM2.3335Y4.816-2.483
5Y4.81610Y4.247+0.569
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7213.905-0.184
TTM2.3334.212-1.879
YOY3.6515.337-1.686
5Y4.8166.062-1.246
10Y4.2476.401-2.154
1.3.2. Quick Ratio

Measures if Active Biotech AB is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Active Biotech AB to the Biotechnology industry mean.
  • A Quick Ratio of 3.72 means the company can pay off kr3.72 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Active Biotech AB:

  • The MRQ is 3.721. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.333. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.721TTM2.333+1.388
TTM2.333YOY3.648-1.315
TTM2.3335Y4.724-2.391
5Y4.72410Y3.375+1.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7213.572+0.149
TTM2.3334.001-1.668
YOY3.6485.364-1.716
5Y4.7246.009-1.285
10Y3.3756.287-2.912

1.4. Solvency of Active Biotech AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Active Biotech AB assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Active Biotech AB to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that Active Biotech AB assets are financed with 30.5% credit (debt) and the remaining percentage (100% - 30.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Active Biotech AB:

  • The MRQ is 0.305. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.537. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.305TTM0.537-0.232
TTM0.537YOY0.331+0.206
TTM0.5375Y0.311+0.226
5Y0.31110Y0.453-0.142
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3050.336-0.031
TTM0.5370.334+0.203
YOY0.3310.271+0.060
5Y0.3110.366-0.055
10Y0.4530.389+0.064
1.4.2. Debt to Equity Ratio

Measures if Active Biotech AB is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Active Biotech AB to the Biotechnology industry mean.
  • A Debt to Equity ratio of 43.6% means that company has kr0.44 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Active Biotech AB:

  • The MRQ is 0.436. The company is very able to pay all its debts with equity. +2
  • The TTM is 3.055. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ0.436TTM3.055-2.619
TTM3.055YOY0.529+2.526
TTM3.0555Y0.979+2.076
5Y0.97910Y1.295-0.316
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4360.382+0.054
TTM3.0550.397+2.658
YOY0.5290.341+0.188
5Y0.9790.432+0.547
10Y1.2950.465+0.830

2. Market Valuation of Active Biotech AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Active Biotech AB generates.

  • Above 15 is considered overpriced but always compare Active Biotech AB to the Biotechnology industry mean.
  • A PE ratio of -3.30 means the investor is paying kr-3.30 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Active Biotech AB:

  • The EOD is -3.979. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.303. Based on the earnings, the company is expensive. -2
  • The TTM is -5.679. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.979MRQ-3.303-0.676
MRQ-3.303TTM-5.679+2.376
TTM-5.679YOY-6.596+0.917
TTM-5.6795Y-16.714+11.035
5Y-16.71410Y-29.752+13.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.979-2.262-1.717
MRQ-3.303-2.599-0.704
TTM-5.679-2.674-3.005
YOY-6.596-4.133-2.463
5Y-16.714-6.258-10.456
10Y-29.752-6.171-23.581
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Active Biotech AB:

  • The EOD is -4.563. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.787. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.692. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.563MRQ-3.787-0.776
MRQ-3.787TTM-5.692+1.904
TTM-5.692YOY-6.975+1.284
TTM-5.6925Y-13.389+7.698
5Y-13.38910Y-27.048+13.659
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.563-2.913-1.650
MRQ-3.787-3.275-0.512
TTM-5.692-3.508-2.184
YOY-6.975-5.620-1.355
5Y-13.389-8.306-5.083
10Y-27.048-8.854-18.194
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Active Biotech AB is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.40 means the investor is paying kr5.40 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Active Biotech AB:

  • The EOD is 6.502. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.397. Based on the equity, the company is overpriced. -1
  • The TTM is 62.316. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.502MRQ5.397+1.105
MRQ5.397TTM62.316-56.920
TTM62.316YOY14.106+48.211
TTM62.3165Y25.273+37.043
5Y25.27310Y23.374+1.899
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.5021.858+4.644
MRQ5.3972.090+3.307
TTM62.3162.091+60.225
YOY14.1062.866+11.240
5Y25.2733.488+21.785
10Y23.3743.836+19.538
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Active Biotech AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.081-0.003+103%-0.009+111%-0.008+110%-0.026+132%
Book Value Per Share--0.0850.046+83%0.091-7%0.120-29%0.328-74%
Current Ratio--3.7212.333+59%3.651+2%4.816-23%4.247-12%
Debt To Asset Ratio--0.3050.537-43%0.331-8%0.311-2%0.453-33%
Debt To Equity Ratio--0.4363.055-86%0.529-18%0.979-55%1.295-66%
Dividend Per Share----0%-0%-0%-0%
Eps---0.035-0.032-8%-0.040+17%-0.030-12%-0.059+70%
Free Cash Flow Per Share---0.030-0.032+5%-0.038+26%-0.030-1%-0.060+98%
Free Cash Flow To Equity Per Share--0.085-0.004+105%-0.008+109%-0.037+143%-0.043+150%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.190--------
Intrinsic Value_10Y_min---4.373--------
Intrinsic Value_1Y_max---0.148--------
Intrinsic Value_1Y_min---0.274--------
Intrinsic Value_3Y_max---0.499--------
Intrinsic Value_3Y_min---0.970--------
Intrinsic Value_5Y_max---0.916--------
Intrinsic Value_5Y_min---1.823--------
Market Cap198956454.400+17%165133857.152256970347.808-36%384890304.512-57%598942127.716-72%2549575415.327-94%
Net Profit Margin----0%-0%-2.9780%-5.0330%
Operating Margin----0%-0%-2.8380%-4.7120%
Operating Ratio----0%-0%3.440-100%5.370-100%
Pb Ratio6.502+17%5.39762.316-91%14.106-62%25.273-79%23.374-77%
Pe Ratio-3.979-20%-3.303-5.679+72%-6.596+100%-16.714+406%-29.752+801%
Price Per Share0.550+17%0.4570.710-36%1.064-57%1.656-72%7.048-94%
Price To Free Cash Flow Ratio-4.563-20%-3.787-5.692+50%-6.975+84%-13.389+254%-27.048+614%
Price To Total Gains Ratio6.790+17%5.636-18.054+420%-17.270+406%-61.958+1199%-104.009+1945%
Quick Ratio--3.7212.333+59%3.648+2%4.724-21%3.375+10%
Return On Assets---0.284-0.441+55%-0.334+18%-0.246-14%-0.155-45%
Return On Equity---0.407-2.497+513%-0.528+30%-0.721+77%-0.445+9%
Total Gains Per Share--0.081-0.003+103%-0.009+111%-0.008+110%-0.026+132%
Usd Book Value--2812140.0001534730.000+83%3023762.725-7%3988032.665-29%10905687.993-74%
Usd Book Value Change Per Share--0.0070.000+103%-0.001+111%-0.001+110%-0.002+132%
Usd Book Value Per Share--0.0080.004+83%0.008-7%0.011-29%0.030-74%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.003-8%-0.004+17%-0.003-12%-0.005+70%
Usd Free Cash Flow---1001710.000-1052255.000+5%-1265807.625+26%-988338.550-1%-1980961.938+98%
Usd Free Cash Flow Per Share---0.003-0.003+5%-0.003+26%-0.003-1%-0.005+98%
Usd Free Cash Flow To Equity Per Share--0.0080.000+105%-0.001+109%-0.003+143%-0.004+150%
Usd Market Cap18284098.159+17%15175801.47223615574.964-36%35371418.985-57%55042781.537-72%234305980.669-94%
Usd Price Per Share0.051+17%0.0420.065-36%0.098-57%0.152-72%0.648-94%
Usd Profit---1148750.000-1045362.500-9%-1366047.550+19%-1009682.325-12%-1952950.818+70%
Usd Revenue----0%-0%47098.750-100%178508.858-100%
Usd Total Gains Per Share--0.0070.000+103%-0.001+111%-0.001+110%-0.002+132%
 EOD+6 -2MRQTTM+21 -8YOY+21 -85Y+13 -1810Y+20 -11

3.2. Fundamental Score

Let's check the fundamental score of Active Biotech AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.979
Price to Book Ratio (EOD)Between0-16.502
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.721
Current Ratio (MRQ)Greater than13.721
Debt to Asset Ratio (MRQ)Less than10.305
Debt to Equity Ratio (MRQ)Less than10.436
Return on Equity (MRQ)Greater than0.15-0.407
Return on Assets (MRQ)Greater than0.05-0.284
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Active Biotech AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.034
Ma 20Greater thanMa 500.580
Ma 50Greater thanMa 1000.578
Ma 100Greater thanMa 2000.580
OpenGreater thanClose0.561
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  376124500-1004000400-4000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets44,000
Total Liabilities13,400
Total Stockholder Equity30,700
 As reported
Total Liabilities 13,400
Total Stockholder Equity+ 30,700
Total Assets = 44,000

Assets

Total Assets44,000
Total Current Assets38,700
Long-term Assets5,300
Total Current Assets
Cash And Cash Equivalents 36,200
Net Receivables 2,500
Total Current Assets  (as reported)38,700
Total Current Assets  (calculated)38,700
+/-0
Long-term Assets
Property Plant Equipment 4,700
Intangible Assets 200
Other Assets 0
Long-term Assets  (as reported)5,300
Long-term Assets  (calculated)4,900
+/- 400

Liabilities & Shareholders' Equity

Total Current Liabilities10,400
Long-term Liabilities3,000
Total Stockholder Equity30,700
Total Current Liabilities
Other Current Liabilities 10,400
Total Current Liabilities  (as reported)10,400
Total Current Liabilities  (calculated)10,400
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,000
Long-term Liabilities  (calculated)0
+/- 3,000
Total Stockholder Equity
Total Stockholder Equity (as reported)30,700
Total Stockholder Equity (calculated)0
+/- 30,700
Other
Cash and Short Term Investments 36,200
Common Stock Shares Outstanding 285,411
Liabilities and Stockholders Equity 44,000
Net Debt -33,200
Net Working Capital 28,300
Short Long Term Debt Total 3,000



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-12-312000-06-30
> Total Assets 
1,289,400
868,946
704,700
747,741
596,100
467,505
499,800
345,400
322,600
252,400
227,300
312,888
517,000
517,800
628,600
567,864
522,700
501,000
504,100
462,401
642,300
586,500
533,900
489,544
429,800
550,400
498,300
472,948
410,400
604,300
541,900
498,498
443,400
559,800
508,300
503,095
776,700
971,800
901,100
858,516
769,400
775,400
701,300
696,737
865,200
778,600
816,900
767,807
690,500
618,300
550,200
722,520
660,500
575,100
521,800
449,440
407,700
393,800
374,300
412,875
397,700
379,400
366,200
303,813
291,200
323,800
313,300
302,431
293,700
83,900
78,900
66,954
54,200
43,900
36,000
32,155
97,100
83,000
72,700
56,800
42,300
32,800
65,600
51,005
39,500
24,600
14,300
44,000
44,00014,30024,60039,50051,00565,60032,80042,30056,80072,70083,00097,10032,15536,00043,90054,20066,95478,90083,900293,700302,431313,300323,800291,200303,813366,200379,400397,700412,875374,300393,800407,700449,440521,800575,100660,500722,520550,200618,300690,500767,807816,900778,600865,200696,737701,300775,400769,400858,516901,100971,800776,700503,095508,300559,800443,400498,498541,900604,300410,400472,948498,300550,400429,800489,544533,900586,500642,300462,401504,100501,000522,700567,864628,600517,800517,000312,888227,300252,400322,600345,400499,800467,505596,100747,741704,700868,9461,289,400
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179,505
126,700
245,100
195,400
144,579
420,900
613,600
543,400
475,852
386,500
392,900
319,300
315,237
484,400
398,000
436,000
386,772
309,500
237,500
168,000
340,883
279,400
194,400
141,500
119,637
78,400
64,900
45,800
84,803
70,000
376,900
363,800
302,099
289,600
322,400
312,000
301,164
291,500
82,900
75,400
63,763
51,300
41,400
33,800
30,284
95,500
81,800
71,800
55,858
41,500
25,600
58,800
44,120
33,000
18,600
8,700
38,700
38,7008,70018,60033,00044,12058,80025,60041,50055,85871,80081,80095,50030,28433,80041,40051,30063,76375,40082,900291,500301,164312,000322,400289,600302,099363,800376,90070,00084,80345,80064,90078,400119,637141,500194,400279,400340,883168,000237,500309,500386,772436,000398,000484,400315,237319,300392,900386,500475,852543,400613,600420,900144,579195,400245,100126,700179,5050000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
156,035
110,600
235,300
175,900
131,141
411,300
601,300
530,100
465,173
378,400
383,700
308,800
216,661
471,300
389,100
322,200
376,195
298,500
227,700
161,000
328,455
270,500
186,600
132,400
103,617
76,500
57,400
39,900
77,677
62,700
47,700
35,600
25,152
12,800
45,600
36,000
25,552
16,400
77,200
69,900
59,681
47,900
38,200
30,900
26,213
92,000
78,500
68,400
53,100
37,800
21,900
55,000
41,796
30,200
15,700
5,600
36,200
36,2005,60015,70030,20041,79655,00021,90037,80053,10068,40078,50092,00026,21330,90038,20047,90059,68169,90077,20016,40025,55236,00045,60012,80025,15235,60047,70062,70077,67739,90057,40076,500103,617132,400186,600270,500328,455161,000227,700298,500376,195322,200389,100471,300216,661308,800383,700378,400465,173530,100601,300411,300131,141175,900235,300110,600156,0350000000000000000000000000000000
       Net Receivables 
147,600
85,838
94,300
13,611
21,700
17,767
19,900
12,555
17,400
12,000
12,300
7,044
14,400
69,700
8,500
8,840
9,800
9,100
59,200
7,841
21,000
19,200
14,400
9,779
8,600
10,400
13,100
6,725
13,200
21,700
18,700
12,006
16,100
9,800
19,500
6,800
9,600
12,300
13,300
4,343
8,100
9,200
10,500
92,143
13,100
9,000
113,800
6,840
10,900
9,900
7,000
5,653
8,800
7,700
9,100
13,925
1,900
7,500
5,900
4,902
7,300
7,400
6,500
2,866
5,100
5,000
4,200
2,038
3,400
5,700
5,500
2,610
3,400
3,200
3,000
1,514
3,500
3,300
3,400
1,190
3,600
3,700
3,800
2,300
2,800
2,900
3,100
2,500
2,5003,1002,9002,8002,3003,8003,7003,6001,1903,4003,3003,5001,5143,0003,2003,4002,6105,5005,7003,4002,0384,2005,0005,1002,8666,5007,4007,3004,9025,9007,5001,90013,9259,1007,7008,8005,6537,0009,90010,9006,840113,8009,00013,10092,14310,5009,2008,1004,34313,30012,3009,6006,80019,5009,80016,10012,00618,70021,70013,2006,72513,10010,4008,6009,77914,40019,20021,0007,84159,2009,1009,8008,8408,50069,70014,4007,04412,30012,00017,40012,55519,90017,76721,70013,61194,30085,838147,600
       Other Current Assets 
0
13,765
0
11,793
0
12,494
0
9,900
0
0
0
8,550
0
0
0
801
0
0
0
6,140
0
0
0
8,999
0
0
0
2,929
0
0
0
23,470
16,100
9,800
19,500
13,438
9,600
12,300
13,300
10,679
8,100
9,200
10,500
98,576
13,100
8,900
113,800
10,577
11,000
9,800
7,000
12,428
8,900
7,800
9,100
16,020
1,900
7,500
5,900
7,126
7,300
329,200
328,200
276,947
276,800
276,800
276,000
275,612
275,100
5,700
5,500
4,082
3,400
3,200
2,900
4,071
3,500
3,300
3,400
100
100
3,700
3,800
0
3
3
0
0
003303,8003,7001001003,4003,3003,5004,0712,9003,2003,4004,0825,5005,700275,100275,612276,000276,800276,800276,947328,200329,2007,3007,1265,9007,5001,90016,0209,1007,8008,90012,4287,0009,80011,00010,577113,8008,90013,10098,57610,5009,2008,10010,67913,30012,3009,60013,43819,5009,80016,10023,4700002,9290008,9990006,1400008010008,5500009,900012,494011,793013,7650
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
318,993
316,700
314,700
312,900
358,516
355,800
358,200
357,700
382,664
382,900
382,500
382,000
381,500
380,800
380,600
380,900
381,035
381,000
380,800
382,200
381,637
381,100
380,800
380,300
329,803
329,400
328,900
328,500
328,072
327,700
2,500
2,300
1,714
1,600
1,400
1,300
1,267
2,200
1,000
3,500
3,191
2,900
2,500
2,200
1,871
1,500
1,200
900
946
900
7,200
6,900
6,885
6,500
6,000
5,600
5,300
5,3005,6006,0006,5006,8856,9007,2009009469001,2001,5001,8712,2002,5002,9003,1913,5001,0002,2001,2671,3001,4001,6001,7142,3002,500327,700328,072328,500328,900329,400329,803380,300380,800381,100381,637382,200380,800381,000381,035380,900380,600380,800381,500382,000382,500382,900382,664357,700358,200355,800358,516312,900314,700316,700318,9930000000000000000000000000000000
       Property Plant Equipment 
196,200
197,447
206,500
74,256
66,000
60,196
56,300
50,303
47,300
44,800
41,400
39,060
308,000
303,100
381,600
376,899
371,900
358,200
352,700
347,703
343,400
338,800
334,100
329,700
326,600
325,900
324,700
324,552
325,500
323,100
321,100
318,992
316,800
314,700
312,900
358,515
355,800
358,200
357,700
382,663
382,900
382,500
382,000
381,499
380,800
380,600
380,900
381,034
381,000
380,800
382,200
381,636
381,100
380,800
380,300
329,802
329,400
328,900
328,500
328,071
327,700
2,500
2,300
1,713
1,600
1,400
1,300
1,266
2,200
1,000
3,500
3,190
2,900
2,500
2,200
1,870
1,500
1,200
900
945
600
6,600
6,200
6,264
5,800
5,400
5,000
4,700
4,7005,0005,4005,8006,2646,2006,6006009459001,2001,5001,8702,2002,5002,9003,1903,5001,0002,2001,2661,3001,4001,6001,7132,3002,500327,700328,071328,500328,900329,400329,802380,300380,800381,100381,636382,200380,800381,000381,034380,900380,600380,800381,499382,000382,500382,900382,663357,700358,200355,800358,515312,900314,700316,800318,992321,100323,100325,500324,552324,700325,900326,600329,700334,100338,800343,400347,703352,700358,200371,900376,899381,600303,100308,00039,06041,40044,80047,30050,30356,30060,19666,00074,256206,500197,447196,200
       Intangible Assets 
339,800
47,141
45,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
200
245
200
200
200
200
2002002002002452002002000000000000000000000000000000000000000000000000000000000000000000000000000000045,40047,141339,800
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-100
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
2,200
1,000
3,500
1
2,900
0
0
1
0
0
0
0
100
400
500
376
500
400
400
0
040040050037650040010000001002,90013,5001,0002,20010001000100010001000100010001000100-10010000000000000000000000000000000
> Total Liabilities 
282,500
222,918
234,500
68,958
49,000
87,238
42,200
55,822
75,900
40,500
48,600
150,588
466,100
470,800
415,000
391,050
388,300
388,200
390,200
402,043
303,500
303,000
289,200
299,974
292,700
305,600
316,300
309,338
309,200
309,900
294,400
309,857
301,400
302,600
299,300
321,337
297,100
319,300
326,000
356,526
364,600
393,200
368,900
356,819
331,500
324,300
331,400
362,396
343,300
326,900
313,400
317,214
311,200
295,200
263,400
268,837
242,000
241,600
232,600
230,320
229,000
233,100
228,400
226,136
224,100
218,300
216,500
214,516
213,900
9,600
13,900
13,171
10,500
10,100
10,100
10,042
10,600
9,100
9,900
8,900
11,300
15,900
16,400
16,494
16,500
12,700
13,000
13,400
13,40013,00012,70016,50016,49416,40015,90011,3008,9009,9009,10010,60010,04210,10010,10010,50013,17113,9009,600213,900214,516216,500218,300224,100226,136228,400233,100229,000230,320232,600241,600242,000268,837263,400295,200311,200317,214313,400326,900343,300362,396331,400324,300331,500356,819368,900393,200364,600356,526326,000319,300297,100321,337299,300302,600301,400309,857294,400309,900309,200309,338316,300305,600292,700299,974289,200303,000303,500402,043390,200388,200388,300391,050415,000470,800466,100150,58848,60040,50075,90055,82242,20087,23849,00068,958234,500222,918282,500
   > Total Current Liabilities 
159,100
129,849
107,400
59,885
39,900
84,559
36,000
50,892
71,000
35,200
43,800
52,116
73,000
77,200
36,100
36,312
35,700
34,300
37,600
147,186
49,600
50,000
37,600
49,342
42,200
53,100
64,900
57,612
55,900
58,200
44,200
61,901
55,100
57,800
55,700
79,667
57,300
79,200
89,600
121,730
131,000
161,400
138,900
128,340
105,000
98,900
106,500
138,350
115,900
100,900
89,100
94,575
90,100
75,700
45,400
52,565
27,300
28,500
21,000
23,362
20,400
25,900
22,600
225,839
223,900
218,100
216,300
214,412
212,900
8,500
11,600
11,170
8,800
8,700
9,100
9,353
10,200
8,900
9,800
9,904
11,100
11,100
12,000
12,062
12,400
9,100
9,600
10,400
10,4009,6009,10012,40012,06212,00011,10011,1009,9049,8008,90010,2009,3539,1008,7008,80011,17011,6008,500212,900214,412216,300218,100223,900225,83922,60025,90020,40023,36221,00028,50027,30052,56545,40075,70090,10094,57589,100100,900115,900138,350106,50098,900105,000128,340138,900161,400131,000121,73089,60079,20057,30079,66755,70057,80055,10061,90144,20058,20055,90057,61264,90053,10042,20049,34237,60050,00049,600147,18637,60034,30035,70036,31236,10077,20073,00052,11643,80035,20071,00050,89236,00084,55939,90059,885107,400129,849159,100
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,523
0
0
0
15,558
0
0
0
8,010
0
0
0
8,036
0
0
0
6,899
0
0
0
6,898
0
0
0
6,490
0
0
0
9,320
208,600
207,300
205,800
210,115
223,900
218,100
216,300
204,246
212,900
8,500
11,600
1,252
0
0
0
1,312
0
0
0
0
0
0
0
1,606
0
0
0
0
00001,60600000001,3120001,25211,6008,500212,900204,246216,300218,100223,900210,115205,800207,300208,6009,3200006,4900006,8980006,8990008,0360008,01000015,5580007,5230000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
216,278
208,600
207,300
205,800
209,433
223,900
218,100
216,300
204,053
212,900
8,500
11,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000011,6008,500212,900204,053216,300218,100223,900209,433205,800207,300208,600216,27800000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
77,768
0
27,629
0
32,923
0
25,029
0
0
0
15,427
0
0
0
7,337
0
0
0
14,034
0
0
0
10,432
0
0
0
16,213
0
0
0
13,325
0
0
0
27,454
0
0
0
27,807
0
0
0
42,081
0
0
0
34,353
0
0
14,918
24,432
0
0
0
6,625
0
0
0
3,898
0
0
0
3,629
0
0
0
3,988
0
0
0
5,598
0
0
0
2,852
0
0
0
2,761
0
0
0
3,528
0
0
0
0
00003,5280002,7610002,8520005,5980003,9880003,6290003,8980006,62500024,43214,9180034,35300042,08100027,80700027,45400013,32500016,21300010,43200014,0340007,33700015,42700025,029032,923027,629077,7680
       Other Current Liabilities 
0
49,136
0
29,033
0
48,978
0
24,124
0
0
0
34,682
73,000
77,200
36,100
23,214
35,700
34,300
37,600
29,267
49,600
50,000
37,600
33,402
42,200
53,100
64,900
34,747
55,900
58,200
44,200
41,053
55,100
57,800
55,700
36,655
57,300
79,200
89,600
85,913
131,000
161,400
138,900
78,223
105,000
98,900
106,500
97,098
115,900
100,900
89,100
63,245
90,100
75,700
45,400
39,450
27,300
28,500
21,000
10,144
20,400
25,900
22,600
12,095
223,900
218,100
216,300
6,178
212,900
8,500
11,600
4,320
8,800
8,700
9,100
5,189
10,200
8,900
9,800
408
11,100
11,100
12,000
6,928
12,400
9,100
9,600
10,400
10,4009,6009,10012,4006,92812,00011,10011,1004089,8008,90010,2005,1899,1008,7008,8004,32011,6008,500212,9006,178216,300218,100223,90012,09522,60025,90020,40010,14421,00028,50027,30039,45045,40075,70090,10063,24589,100100,900115,90097,098106,50098,900105,00078,223138,900161,400131,00085,91389,60079,20057,30036,65555,70057,80055,10041,05344,20058,20055,90034,74764,90053,10042,20033,40237,60050,00049,60029,26737,60034,30035,70023,21436,10077,20073,00034,68200024,124048,978029,033049,1360
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
247,956
246,300
244,800
243,600
241,670
239,800
240,100
236,400
234,796
233,600
231,800
230,000
228,479
226,500
225,400
224,900
224,046
227,400
226,000
224,300
222,639
221,100
219,500
218,000
216,272
214,700
213,100
211,600
206,958
208,600
207,200
205,800
297
200
200
200
104
1,000
1,100
2,300
2,001
1,700
1,400
1,000
689
400
200
100
226
200
4,800
4,400
4,432
4,100
3,600
3,400
3,000
3,0003,4003,6004,1004,4324,4004,8002002261002004006891,0001,4001,7002,0012,3001,1001,000104200200200297205,800207,200208,600206,958211,600213,100214,700216,272218,000219,500221,100222,639224,300226,000227,400224,046224,900225,400226,500228,479230,000231,800233,600234,796236,400240,100239,800241,670243,600244,800246,300247,9560000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
689
400
100
100
200
200
4,800
4,500
4,400
4,100
3,700
0
0
003,7004,1004,4004,5004,800200200100100400689000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
9,073
0
2,679
0
0
0
0
0
0
0
0
17,700
0
0
0
0
0
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
0
0
0
0
0
0
0
100
0
0
100
0
100
0
100
0
0
0
0
-100
0
0
0
0
100
0
-100
100
0
0
0
100
1,000
0
0
100
100
200
0
0
-100
0
0
-100
0
0
00-10000-10000200100100001,000100000100-10001000000-100000010001000100001000000000000100000000000000000010000000017,700000000002,67909,073000
> Total Stockholder Equity
1,006,900
646,028
470,200
678,783
547,100
380,267
457,600
289,578
246,700
211,900
178,700
162,300
50,900
47,000
213,600
176,814
134,400
112,800
113,900
60,358
338,800
283,500
244,700
189,570
137,100
244,800
182,000
163,610
101,200
294,400
247,500
188,641
142,000
257,200
209,000
181,758
479,600
652,500
575,100
501,990
404,800
382,200
332,400
339,918
533,700
454,300
485,500
405,411
347,200
291,400
236,800
405,306
349,300
279,900
258,400
180,603
165,700
152,200
141,700
182,555
168,700
146,300
137,800
77,677
67,100
105,500
96,800
87,915
79,800
74,300
65,000
53,783
43,700
33,800
25,900
22,113
86,500
73,900
62,800
47,900
31,000
16,900
49,200
34,511
23,000
11,900
1,300
30,700
30,7001,30011,90023,00034,51149,20016,90031,00047,90062,80073,90086,50022,11325,90033,80043,70053,78365,00074,30079,80087,91596,800105,50067,10077,677137,800146,300168,700182,555141,700152,200165,700180,603258,400279,900349,300405,306236,800291,400347,200405,411485,500454,300533,700339,918332,400382,200404,800501,990575,100652,500479,600181,758209,000257,200142,000188,641247,500294,400101,200163,610182,000244,800137,100189,570244,700283,500338,80060,358113,900112,800134,400176,814213,60047,00050,900162,300178,700211,900246,700289,578457,600380,267547,100678,783470,200646,0281,006,900
   Common Stock
0
281,157
0
281,157
0
281,157
0
337,389
0
0
0
337,389
50,900
47,000
213,600
395,922
134,400
112,800
113,900
150,003
338,800
283,500
244,700
178,290
137,100
244,800
182,000
193,148
101,200
294,400
247,500
241,435
142,000
257,200
209,000
248,776
479,600
652,500
575,100
259,797
404,800
382,200
332,400
259,797
533,700
454,300
485,500
282,413
347,200
291,400
236,800
338,896
349,300
279,900
258,400
338,895
165,700
152,200
141,700
364,964
168,700
146,300
137,800
500
67,100
105,500
96,800
750
79,800
74,300
65,000
750
43,700
33,800
25,900
750
86,500
73,900
62,800
1,126
31,000
16,900
49,200
1,368
23
12
1,300
0
01,30012231,36849,20016,90031,0001,12662,80073,90086,50075025,90033,80043,70075065,00074,30079,80075096,800105,50067,100500137,800146,300168,700364,964141,700152,200165,700338,895258,400279,900349,300338,896236,800291,400347,200282,413485,500454,300533,700259,797332,400382,200404,800259,797575,100652,500479,600248,776209,000257,200142,000241,435247,500294,400101,200193,148182,000244,800137,100178,290244,700283,500338,800150,003113,900112,800134,400395,922213,60047,00050,900337,389000337,3890281,1570281,1570281,1570
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,313,639
0
0
0
2,512,583
0
0
0
2,914,868
0
0
0
2,925,820
0
0
0
3,178,555
0
0
0
3,351,251
0
0
0
3,317,852
0
0
0
3,351,091
0
0
0
3,353,891
0
0
0
3,400,757
0
0
0
3,311,868
43,700
33,800
25,900
3,311,868
86,500
73,900
62,800
47,900
31,000
16,900
49,200
3,430,872
22,977
11,888
0
0
0011,88822,9773,430,87249,20016,90031,00047,90062,80073,90086,5003,311,86825,90033,80043,7003,311,8680003,400,7570003,353,8910003,351,0910003,317,8520003,351,2510003,178,5550002,925,8200002,914,8680002,512,5830002,313,6390000000000000000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,700
Gross Profit-1,700-1,700
 
Operating Income (+$)
Gross Profit-1,700
Operating Expense-44,700
Operating Income-46,400-46,400
 
Operating Expense (+$)
Research Development32,500
Selling General Administrative15,662
Selling And Marketing Expenses0
Operating Expense44,70048,162
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-943
Net Interest Income943
 
Pretax Income (+$)
Operating Income-46,400
Net Interest Income943
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-45,800-47,000
EBIT - interestExpense = -46,400
-45,800
-45,800
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-46,400-45,800
Earnings Before Interest and Taxes (EBITDA)-44,700
 
After tax Income (+$)
Income Before Tax-45,800
Tax Provision-0
Net Income From Continuing Ops-48,272-45,800
Net Income-45,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses46,400
Total Other Income/Expenses Net600-943
 

Technical Analysis of Active Biotech AB
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Active Biotech AB. The general trend of Active Biotech AB is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Active Biotech AB's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Active Biotech AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.564 < 0.62 < 0.67.

The bearish price targets are: 0.529 > 0.52 > 0.516.

Tweet this
Active Biotech AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Active Biotech AB. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Active Biotech AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Active Biotech AB. The current macd is -0.0073662.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Active Biotech AB price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Active Biotech AB. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Active Biotech AB price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Active Biotech AB Daily Moving Average Convergence/Divergence (MACD) ChartActive Biotech AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Active Biotech AB. The current adx is 19.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Active Biotech AB shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Active Biotech AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Active Biotech AB. The current sar is 0.61910656.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Active Biotech AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Active Biotech AB. The current rsi is 42.03. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Active Biotech AB Daily Relative Strength Index (RSI) ChartActive Biotech AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Active Biotech AB. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Active Biotech AB price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Active Biotech AB Daily Stochastic Oscillator ChartActive Biotech AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Active Biotech AB. The current cci is -108.18949804.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Active Biotech AB Daily Commodity Channel Index (CCI) ChartActive Biotech AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Active Biotech AB. The current cmo is -25.73366113.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Active Biotech AB Daily Chande Momentum Oscillator (CMO) ChartActive Biotech AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Active Biotech AB. The current willr is -59.76095618.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Active Biotech AB is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Active Biotech AB Daily Williams %R ChartActive Biotech AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Active Biotech AB.

Active Biotech AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Active Biotech AB. The current atr is 0.04404648.

Active Biotech AB Daily Average True Range (ATR) ChartActive Biotech AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Active Biotech AB. The current obv is -31,309,448.

Active Biotech AB Daily On-Balance Volume (OBV) ChartActive Biotech AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Active Biotech AB. The current mfi is 30.36.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Active Biotech AB Daily Money Flow Index (MFI) ChartActive Biotech AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Active Biotech AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Active Biotech AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Active Biotech AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.034
Ma 20Greater thanMa 500.580
Ma 50Greater thanMa 1000.578
Ma 100Greater thanMa 2000.580
OpenGreater thanClose0.561
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Active Biotech AB with someone you think should read this too:
  • Are you bullish or bearish on Active Biotech AB? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Active Biotech AB? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Active Biotech AB

I send you an email if I find something interesting about Active Biotech AB.


Comments

How you think about this?

Leave a comment

Stay informed about Active Biotech AB.

Receive notifications about Active Biotech AB in your mailbox!